Next Article in Journal
Role of Ivermectin in Patients Hospitalized with COVID-19: A Systematic Review of Literature
Previous Article in Journal
Potential Benefits and Hazards Associated with the Use of E-Cigarettes—A Guide for Practitioners and Current Status in Poland
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
ARM
Volume 89
Issue 4
10.5603/ARM.a2021.0075
arm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Endocrine Paraneoplastic Syndromes in Lung Cancer: A Respiratory Physician’s Perspective

by
Pratap Upadhya
1,*,
Arpitha Ananthraju
2,
Rohit Vadala
3 and
Madhusmita Mohanty Mohapatra
1
1
Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India
2
Department of Obstetrics and Gynecology, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India
3
Department of Pulmonary Medicine, All India Institute of Medical Sciences, New Delhi, India
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2021, 89(4), 403-412; https://doi.org/10.5603/ARM.a2021.0075
Submission received: 1 January 2021 / Revised: 19 June 2021 / Accepted: 19 June 2021 / Published: 2 September 2021

Abstract

Lung malignancy is known to be one of the leading causes of cancer-related mortality. Endocrine paraneoplastic syndromes in lung cancer are common. These are due to secretion of various substances and not because of direct tumour invasion or me-tastasis. These syndromes have also been associated with lung cancer prognosis. This review describes the many endocrine paraneoplastic syndromes seen in lung cancer and narrates their incidence, biology, clinical features, diagnosis, and management.
Keywords: endocrine paraneoplastic syndromes; lung cancer; hypercalcaemia; hyponatraemia; small-cell lung carcinoma endocrine paraneoplastic syndromes; lung cancer; hypercalcaemia; hyponatraemia; small-cell lung carcinoma

Share and Cite

MDPI and ACS Style

Upadhya, P.; Ananthraju, A.; Vadala, R.; Mohapatra, M.M. Endocrine Paraneoplastic Syndromes in Lung Cancer: A Respiratory Physician’s Perspective. Adv. Respir. Med. 2021, 89, 403-412. https://doi.org/10.5603/ARM.a2021.0075

AMA Style

Upadhya P, Ananthraju A, Vadala R, Mohapatra MM. Endocrine Paraneoplastic Syndromes in Lung Cancer: A Respiratory Physician’s Perspective. Advances in Respiratory Medicine. 2021; 89(4):403-412. https://doi.org/10.5603/ARM.a2021.0075

Chicago/Turabian Style

Upadhya, Pratap, Arpitha Ananthraju, Rohit Vadala, and Madhusmita Mohanty Mohapatra. 2021. "Endocrine Paraneoplastic Syndromes in Lung Cancer: A Respiratory Physician’s Perspective" Advances in Respiratory Medicine 89, no. 4: 403-412. https://doi.org/10.5603/ARM.a2021.0075

Article Metrics

Back to TopTop